TP53 and endometrial endometrioid adenocarcinoma: Multiple studies in solid tumors have demonstrated an inverse relationship between TP53 and ARID1A mutations and even found ARID1A and TP53 mutual exclusivity in ovarian clear cell and uterine endometrioid carcinomas [34, 48].